Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 226

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 226
---
 expenses to us:

|                                                                                                                                                  |     | Per      
 Ordinary 
 Share    |      |     | Total without  
 exercise of    
 over-allotment 
 option         |           |     | Total with       
 full exercise of 
 over-allotment   
 option           |           |
|:-------------------------------------------------------------------------------------------------------------------------------------------------|:----|:---------|-----:|:----|:---------------|----------:|:----|:-----------------|----------:|
| Initial public offering price (the midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus) |     | $        | 5.00 |     | $              | 6,250,000 |     |                  | 7,187,500 |
| Underwriting discounts (6.0%)                                                                                                                    |     | $        | 0.30 |     | $              |   375,000 |     |                  |   431,250 |
| Proceeds, before expenses, to us                                                                                                                 |     | $        | 4.65 |     | $              | 5,875,000 |     |                  | 6,756,250 |

| (1) | We have agreed to pay the Representative a discount equal to                                                        
 seven percent (6.0%) of the gross proceeds of this offering and each closing of the over-allotment option (if any). |

<div align='center'>130</div>

We have agreed to pay the Representative a non-accountable
expense allowance in the amount equal to one percent (1%) of the gross proceeds of this offering.

We agreed to reimburse the Representative for reasonable
out-of-pocket accountable expenses of no more than $250,000, regardless of whether this offering is closed.

We advanced an expense deposit of $70,000 to the Representative
upon the execution of the letter of intent between us and the Representative, $80,000 upon the first public filing of this registration
statement and $100,000 upon the effectiveness of this registration statement for the Representative’s anticipated out-of-pocket
expenses. In the event the IPO is terminated or is not successfully closed, any unused portion of the advanced payment will be returned
to us to the extent not actually incurred in accordance with FINRA Rule 5110(g)(4)(A).

We also agreed to pay to the Representative non-accountable expenses equal
to 1.0% of the gross proceeds raised in this offering.

Lock-Up Agreements

We agreed that, subject to certain exceptions